Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20003 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Rithin Nedumannil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Janus Kinase 2, Primary Myelofibrosis, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: The Wilson Centre for Blood Cancer Genomics, Snowdome Foundation.
Abstract (Originalsprache)
Relapse after allogeneic stem cell transplantation (alloSCT) represents a frequent complication in patients with myelofibrosis (MF). This retrospective study analysed 38 patients with JAK2 ‐mutated MF who underwent alloSCT. Serial sensitive molecular assessments at regular intervals of JAK2 V617F revealed that a ≥2‐fold increase in JAK2 variant allele frequency (VAF) at days +100 and +180 post‐alloSCT was highly predictive of eventual morphological relapse. The integration of JAK2 VAF monitoring with chimerism analysis into post‐alloSCT care represents a novel strategy for early detection of MF relapse, which may enable timely interventions and improve outcomes in such high‐risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Rithin Nedumannil, Piers Blombery, Jeff Szer, David S Ritchie
Förderung
- The Wilson Centre for Blood Cancer Genomics
- Snowdome Foundation
Zitieren
APA
Nedumannil, R., Karmi, T., Blombery, P., Szer, J., Ritchie, D. S., & Chee, L. C. Y. (2025). Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis. British Journal of Haematology. https://doi.org/10.1111/bjh.20003
Vancouver
Nedumannil R, Karmi T, Blombery P, Szer J, Ritchie DS, Chee LCY. Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis. British Journal of Haematology. 2025. doi:10.1111/bjh.20003
BibTeX
@article{Nedumannil2025,
author = {Nedumannil, Rithin and Karmi, Tal and Blombery, Piers and Szer, Jeff and Ritchie, David S and Chee, Lynette C Y},
title = {Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20003}
}
EUVIMED